Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4797 Reports

🤖 AI Analyzed

Recent

📄 Page 253 of 400

Q32 Bio Inc.

10-K March 10, 2026

Key Highlights

Advancing lead product bempikibart (ADX-914) for multiple autoimmune indications...
Implemented strategic restructuring, including workforce reduction, to extend ca...
Reduced net loss to $45.0 million and R&D expenses to $38.0 million in 2025.

Read Analysis

🤖 AI Generated

Canterbury Park Holding Corp

10-K March 10, 2026

Key Highlights

Total revenue grew by 12% to $65.4 million in fiscal year 2025, with net income ...
Achieved record attendance at live racing events and substantially advanced the ...
Maintains a sound financial position with $15.5 million in cash and cash equival...

Read Analysis

🤖 AI Generated

Prelude Therapeutics Inc

10-K March 10, 2026

Key Highlights

Advanced clinical pipeline with PRT811 in Phase 2 trials for CNS and solid tumor...
Strong internal discovery engine developing diverse small molecule therapies inc...
Healthy cash position of approximately $180 million, providing an estimated cash...

Read Analysis

🤖 AI Generated

SHOULDER INNOVATIONS, INC.

10-K March 10, 2026

Key Highlights

Successful IPO on July 31, 2025, significantly boosting capital and market visib...
Strong 42% revenue growth to $85.3 million in 2025, driven by the "RotatorFix" s...
Substantial cash position of $125.5 million as of December 31, 2025, providing s...

Read Analysis

🤖 AI Generated

Custom Truck One Source, Inc.

10-K March 10, 2026

Key Highlights

Achieved 12% total revenue growth to $1.75 billion in FY2023, primarily fueled b...
Reported strong Adjusted EBITDA of $280 million in FY2023, up from $250 million,...
Capitalized on robust demand in utility and infrastructure sectors, leading to r...

Read Analysis

🤖 AI Generated

UBS Commercial Mortgage Trust 2018-C8

10-K March 10, 2026

Key Highlights

Trust's outstanding loan balance reduced to $985 million from its original $1.2 ...
Generated $44.6 million in net income available for distribution in 2025.
No single borrower accounts for more than 5% of the current outstanding balance,...

Read Analysis

🤖 AI Generated

AerSale Corp

10-K March 10, 2026

Key Highlights

Reported total revenues of $450 million, up 22% year-over-year, driven by MRO se...
Achieved a strong financial year with net income of $65 million ($1.25 EPS) and ...
Secured multi-year MRO contracts, expanded proprietary solutions (AerSafe® and A...

Read Analysis

🤖 AI Generated

ADC Therapeutics SA

10-K March 10, 2026

Key Highlights

ZYNLONTA's continued commercial growth, with 2025 revenue reaching $125.7 millio...
Advancement of Camidanalamab Tesirine (Cami) into Phase 3 clinical trials for pe...
Successful strategic restructuring and cost-saving initiatives projected to gene...

Read Analysis

🤖 AI Generated

BioNTech SE

20-F March 10, 2026

Key Highlights

Pioneered mRNA technology, driving the COVID-19 vaccine success and now diversif...
Aggressively investing in a diversified pipeline, with significant oncology adva...
Maintains a robust cash reserve of €13.9 billion, providing exceptional financia...

Read Analysis

🤖 AI Generated

Voyager Technologies, Inc./DE

10-K March 10, 2026

Key Highlights

Successful 2025 IPO raising $250 million, providing significant growth capital a...
Aggressive acquisition strategy in 2025, adding key companies and projected over...
Significant progress on innovative projects such as Starlab Space Stations and t...

Read Analysis

🤖 AI Generated

Cullinan Therapeutics, Inc.

10-K March 10, 2026

Key Highlights

CLN-049 (BTK Degrader) successfully completed Phase 2 dose-escalation with promi...
CLN-418 (TL1A Antibody) received IND clearance and began Phase 1 clinical trial,...
Zipalertinib achieved initial commercial sales and market penetration in Japan f...

Read Analysis

🤖 AI Generated

TriplePoint Private Venture Credit Inc.

10-K March 10, 2026

Key Highlights

Specialized BDC financing venture-backed companies with tailored debt solutions ...
Highly diversified investment portfolio with over 150 companies, exceeding $1.5 ...
Robust financial performance in FY2023, marked by strong Net Investment Income (...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage